Cytek Biosciences (CTKB) Non Operating Income (2020 - 2026)

Cytek Biosciences' Non Operating Income history runs 7 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• Quarterly Non Operating Income fell 70.61% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.9 million (down 52.8% YoY) and the FY2025 annual result came in at $10.5 million, down 28.87% from the prior year.
• Non Operating Income was $1.1 million for Q1 2026 at Cytek Biosciences, down from $1.6 million in the prior quarter.
• Across five years, Non Operating Income topped out at $7.3 million in Q4 2024 and bottomed at -$946000.0 in Q1 2022.
• A 5-year average of $2.5 million and a median of $2.2 million in 2023 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2023 — Non Operating Income surged 596.47% — and 2025, when it sank 78.7%.
• Cytek Biosciences' Non Operating Income stood at $4.0 million in 2022, then climbed by 5.41% to $4.2 million in 2023, then soared by 72.72% to $7.3 million in 2024, then sank by 78.7% to $1.6 million in 2025, then slumped by 30.26% to $1.1 million in 2026.
• Business Quant data shows CTKB's Non Operating Income at $1.1 million in Q1 2026, $1.6 million in Q4 2025, and $1.4 million in Q3 2025.